Dose range

Site

Φ_{m}

LRT_{2pcon}
Shape

LRT_{2pcon}
Rate

t
_{
0.95
}

LRT_{2plin}
shape

LRT_{2plin}
rate

T
_{
0.95
}


020

Stom

11

2.38

0.59

9.06

1.98

0.65

7.25

5500

Stom

8

2.03

0.62

7.72

1.30

0.55

6.42

020

Liver

37

2.50

0.73

7.63

1.69

0.64

6.58

5500

Liver

37

1.62

0.49

8.39

1.14

0.53

6.16

020

Lung

16

2.47

0.58

9.43

2.09

0.68

7.20

5500

Lung

16

1.81

0.61

7.26

1.38

0.66

5.58

020

Panc

10

2.35

0.61

8.65

2.13

0.71

6.93

5500

Panc

42

1.72

0.52

8.18

1.18

0.60

5.61

020

Leuk

25

2.11

0.62

7.94

1.59

0.67

6.01

5500

Leuk

28

1.87

0.62

7.34

1.25

0.56

6.14

 gamma distributions are fitted to 500 simulations of LRT_{2pcon} for the null hypothesis (β_{0},σ_{0},τ_{0}) = (0,0, arbitrary) and of LRT_{2plin} for the null hypothesis (β_{0},σ_{0},τ_{0}) = (,0, arbitrary) where is the fitted parameter for the linear model. Models include "city" as a control covariate and are fitted at the optimal (integral) latency Φ_{m} for the site and dose range.
 shape: shape parameter of the fitted gamma distribution
 rate: rate parameter of the fitted gamma distribution

t
_{
0.95
}: critical value of the fitted gamma distribution for

T
_{
0.95
}: critical value of the fitted gamma distribution for